bioAffinity Technologies, Inc.

For the period ended Mar 16, 2026. Filed Mar 16, 2026.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Mar 16, 2026 · Filed Mar 16, 2026

Use the contents to explore the available documents and sections.

BIAF$2.72+4.4%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

FIRST AMENDMENT

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.